Literature DB >> 10818424

Autoimmune antiovarian antibodies and their impact on the success of an IVF/ET program.

J Horejsí1, J Martínek, D Nováková, J Madar, M Brandejska.   

Abstract

In previous papers, we referred to studies of the influence of antiovarian autoantibodies on menstrual cycle disorders in adolescent girls. We examined autoantibodies against ooplasma, zona pellucida, membrana granulosa, theca folliculi interna, and lutein cells. In infertile women in the IVF/ET program, we studied the positivity of antiovarian antibodies and cytokines, namely, TNF-alpha and IL-1 beta, in follicular fluid correlated with the following subgroups, characterized by the outcome of in vitro fertilization, as follows: G, pregnant; F, fertilized; N, nonfertilized; and O, no oocyte gained. The presence of autoantibodies corresponds to the success or failure of the IVF/ET program. Our results support the hypothesis that antiovarian autoantibodies play an important role in both the endocrine and the reproductive function of the human ovary and that it can influence them negatively.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10818424     DOI: 10.1111/j.1749-6632.2000.tb06248.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  3 in total

1.  Corticosteroids in patients with antiovarian antibodies undergoing in vitro fertilization: a prospective pilot study.

Authors:  Thierry Forges; Patricia Monnier-Barbarino; Frédérique Guillet-May; Gilbert C Faure; Marie-Christine Béné
Journal:  Eur J Clin Pharmacol       Date:  2006-07-18       Impact factor: 2.953

2.  Possible role of autoimmunity in patients with premature ovarian insufficiency.

Authors:  Renata Košir Pogačnik; Helena Meden Vrtovec; Alenka Vizjak; Alenka Uršula Levičnik; Nina Slabe; Alojz Ihan
Journal:  Int J Fertil Steril       Date:  2013-12-22

Review 3.  The role of autoimmunity in premature ovarian failure.

Authors:  Mahbod Ebrahimi; Firouzeh Akbari Asbagh
Journal:  Iran J Reprod Med       Date:  2015-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.